Huma Ikram

586 total citations
38 papers, 416 citations indexed

About

Huma Ikram is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Huma Ikram has authored 38 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 9 papers in Pharmacology and 8 papers in Psychiatry and Mental health. Recurrent topics in Huma Ikram's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Neuroscience and Neuropharmacology Research (9 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Huma Ikram is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Neuroscience and Neuropharmacology Research (9 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Huma Ikram collaborates with scholars based in Pakistan, Canada and Japan. Huma Ikram's co-authors include Darakhshan Jabeen Haleem, Adnan Maqsood Choudhry, Zia Choudhry, Muhammad Abdul Haleem, Abdül Waheed, Muhammad Farhan, Noreen Samad, Zeba Haque, Shoaib Ahmad and Saida Haider and has published in prestigious journals such as Brain Research, Behavioural Brain Research and Pharmacology Biochemistry and Behavior.

In The Last Decade

Huma Ikram

35 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huma Ikram Pakistan 12 132 107 69 63 61 38 416
U. W. Preuss Germany 12 226 1.7× 90 0.8× 117 1.7× 76 1.2× 40 0.7× 21 487
David Nutt United Kingdom 7 173 1.3× 96 0.9× 114 1.7× 37 0.6× 80 1.3× 10 541
Rubén García‐Cabrerizo Spain 14 145 1.1× 46 0.4× 117 1.7× 96 1.5× 88 1.4× 20 407
Amira Pierucci‐Lagha United States 11 270 2.0× 78 0.7× 140 2.0× 57 0.9× 39 0.6× 13 664
Frederick Petty United States 12 184 1.4× 92 0.9× 53 0.8× 48 0.8× 100 1.6× 18 519
Igor Horrillo Spain 9 227 1.7× 95 0.9× 87 1.3× 170 2.7× 75 1.2× 23 489
J Horodnicki Poland 9 280 2.1× 150 1.4× 91 1.3× 43 0.7× 38 0.6× 20 558
Antonio Noronha United States 10 266 2.0× 39 0.4× 101 1.5× 65 1.0× 54 0.9× 13 624
Alessandro Valzania Italy 12 102 0.8× 67 0.6× 86 1.2× 74 1.2× 87 1.4× 13 391
E. Pinto Belgium 10 145 1.1× 83 0.8× 46 0.7× 30 0.5× 28 0.5× 19 458

Countries citing papers authored by Huma Ikram

Since Specialization
Citations

This map shows the geographic impact of Huma Ikram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huma Ikram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huma Ikram more than expected).

Fields of papers citing papers by Huma Ikram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huma Ikram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huma Ikram. The network helps show where Huma Ikram may publish in the future.

Co-authorship network of co-authors of Huma Ikram

This figure shows the co-authorship network connecting the top 25 collaborators of Huma Ikram. A scholar is included among the top collaborators of Huma Ikram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huma Ikram. Huma Ikram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ikram, Huma, et al.. (2024). Memory enhancing and neuroprotective effects of apomorphine in a rat model of dementia. Metabolic Brain Disease. 39(6). 1051–1063. 1 indexed citations
4.
Ikram, Huma, et al.. (2024). Mitigation of addictive effects induced by lorazepam through concurrent administration of SSRI: Interplay of serotonin and dopamine in caudate and nucleus accumbens.. PubMed. 37(5). 1043–1051.
6.
Haleem, Darakhshan Jabeen, et al.. (2021). Co-treatment with low doses of buspirone prevents rewarding effects of methylphenidate and upregulates expression of 5-HT1A receptor mRNA in the nucleus accumbens. Behavioural Brain Research. 418. 113660–113660. 2 indexed citations
7.
Ikram, Huma & Darakhshan Jabeen Haleem. (2019). Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's dementia.. PubMed. 32(2). 555–562. 11 indexed citations
8.
Ikram, Huma & Darakhshan Jabeen Haleem. (2017). Repeated treatment with reserpine as a progressive animal model of depression.. PubMed. 30(3). 897–902. 25 indexed citations
9.
Ikram, Huma, et al.. (2016). Effects of sugar rich diet on brain serotonin, hyperphagia and anxiety in animal model of both genders.. PubMed. 29(3). 757–63. 10 indexed citations
10.
Haleem, Darakhshan Jabeen, et al.. (2015). Behavioral, hormonal and central serotonin modulating effects of injected leptin. Peptides. 74. 1–8. 18 indexed citations
11.
Ikram, Huma, et al.. (2015). Behavioral deficits in rats following acute administration of glimepiride: Relationship with brain serotonin and dopamine.. PubMed. 28(4). 1181–6. 2 indexed citations
12.
Ikram, Huma, et al.. (2015). Apomorphine induced conditioned place preference and sensitization is greater in rats exposed to unpredictable chronic mild stress.. PubMed. 28(6). 1927–32. 2 indexed citations
13.
Haleem, Darakhshan Jabeen, et al.. (2014). Leptin and other hormonal responses to different stressors: relationship with stress-induced behavioral deficits.. Pakistan Veterinary Journal. 34(4). 504–507. 6 indexed citations
14.
Haleem, Darakhshan Jabeen, Huma Ikram, & Muhammad Abdul Haleem. (2014). Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: Relationship with serotonin and dopamine in the striatum. Brain Research. 1586. 73–82. 16 indexed citations
15.
Choudhry, Zia, et al.. (2014). The mechanism of degeneration of striatal neuronal subtypes in Huntington disease. Annals of Neurosciences. 21(3). 112–4. 50 indexed citations
16.
Ikram, Huma, et al.. (2014). Dose-dependent effects of tryptophan on learning and memory.. PubMed. 27(5). 1131–5. 6 indexed citations
17.
Haleem, Darakhshan Jabeen, Huma Ikram, Saida Haider, Tahira Parveen, & Muhammad Abdul Haleem. (2013). Enhancement and inhibition of apomorphine-induced sensitization in rats exposed to immobilization stress: Relationship with adaptation to stress. Pharmacology Biochemistry and Behavior. 112. 22–28. 15 indexed citations
18.
Ikram, Huma & Darakhshan Jabeen Haleem. (2011). Attenuation of apomorphine-induced sensitization by buspirone. Pharmacology Biochemistry and Behavior. 99(3). 444–450. 24 indexed citations
19.
Fitzpatrick, M. A., Miriam T. Rademaker, Christopher J. Charles, et al.. (1992). Comparison of the Effect of Renin Inhibition and Angiotensin-Converting Enzyme Inhibition in Ovine Heart Failure. Journal of Cardiovascular Pharmacology. 19(2). 169–175. 11 indexed citations
20.
Chambers, Stephen T., M. Gary Nicholls, Eric A. Espiner, Huma Ikram, & James Livesey. (1985). Hormone and Haemodynamic Effects of Angiotensin II Infusion during Captopril Treatment for Heart Failure. Hormone and Metabolic Research. 17(3). 159–162. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026